Related Experiment Videos
Secondary metabolic effects in complex I deficiency.
Nayla Esteitie1, Reetta Hinttala, Rolf Wibom
1Department of Women and Childrens Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Annals of Neurology
|July 27, 2005
Summary
Mutations in mitochondrial NADH dehydrogenase (complex I) genes are frequent causes of complex I deficiency, impacting ATP production and Krebs cycle regulation. This research highlights genetic factors in complex I deficiency pathogenesis.
Area of Science:
- Biochemistry
- Genetics
- Mitochondrial Medicine
Background:
- Nicotinamide adenine dinucleotide (NADH) dehydrogenase (complex I) deficiency is a significant cause of mitochondrial disease.
- Genetic mutations in mitochondrial DNA (mtDNA) are implicated in complex I dysfunction.
Purpose of the Study:
- To investigate the clinical, biochemical, and genetic characteristics of patients with complex I deficiency.
- To identify pathogenic mutations in mitochondrial NADH dehydrogenase subunit (MTND) genes.
Main Methods:
- Screening of mitochondrial DNA for mutations in complex I genes.
- Biochemical assessment of respiratory chain function in muscle mitochondria.
- Analysis of secondary metabolic alterations, including Krebs cycle intermediates.
Main Results:
- Pathogenic mutations in MTND genes were identified in three probands.
- Specific mutations (10191T>C in MTND3, 14487T>C in MTND6, 11778G>A in MTND4) were associated with distinct clinical phenotypes.
- All patients exhibited reduced mitochondrial ATP production and secondary metabolic alterations, including Krebs cycle dysregulation.
Conclusions:
- Mutations in MTND genes are a common cause of complex I deficiency.
- Complex I deficiency leads to secondary metabolic disturbances, suggesting a role in disease pathogenesis.
- Altered metabolic regulation is a key factor in the development of complex I deficiency.